MR

Maury Raycroft Jefferies Latest Price Targets & Analyst Ratings

Stock Price Price Target Upside
Downside
Rating Date
ALNY icon
1
Alnylam Pharmaceuticals
ALNY
$59.5B
$453.68 $384
15%
downside
Buy 1 month ago
CMPX icon
2
Compass Therapeutics
CMPX
$478M
$3.46 $8
131%
upside
Buy 6 months ago
MREO
3
Mereo BioPharma
MREO
$286M
$1.80 $7
289%
upside
Buy 9 months ago
ERAS icon
4
Erasca
ERAS
$397M
$1.40 $6
329%
upside
Buy 9 months ago
TNGX icon
5
Tango Therapeutics
TNGX
$749M
$6.73 $19
182%
upside
Buy 1 year ago
PRME icon
6
Prime Medicine
PRME
$608M
$3.41 $15
340%
upside
Buy 1 year ago
DNTH icon
7
Dianthus Therapeutics
DNTH
$777M
$24.14 $39
62%
upside
Buy 1 year ago
BCRX icon
8
BioCryst Pharmaceuticals
BCRX
$1.74B
$8.31 $11
32%
upside
Buy 2 years ago
VERA icon
9
Vera Therapeutics
VERA
$1.46B
$22.94 $6
74%
downside
Hold 2 years ago
ARWR icon
10
Arrowhead Research
ARWR
$3.78B
$27.34 $75
174%
upside
Buy 2 years ago
RZLT icon
11
Rezolute
RZLT
$627M
$7.21 $11
53%
upside
Buy 3 years ago
TYRA icon
12
Tyra Biosciences
TYRA
$690M
$12.95 $27
108%
upside
Buy 3 years ago
CELC icon
13
Celcuity
CELC
$2.28B
$53.84 $48
11%
downside
Buy 4 years ago
VALN
14
Valneva
VALN
$758M
$8.91 $36
304%
upside
Buy 4 years ago
SLDB icon
15
Solid Biosciences
SLDB
$432M
$5.55 $105
1,792%
upside
Buy 4 years ago
CRSP icon
16
CRISPR Therapeutics
CRSP
$4.96B
$54.52 $172
215%
upside
Buy 4 years ago